check_circleStudy Completed

Diagnostic imaging

Study on the safety and efficacy of Gd-DTPA (SH L 451 AA) in magnetic resonance imaging (MRI) of CNS lesions in children

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

Both

Age

6 - 12 Years
  • -

  • -

Trial summary

Enrollment Goal
26
Trial Dates
January 1987 - October 1988
Phase
Phase 3
Could I Receive a placebo
N/A
Products
Magnevist (Gadopentetate Dimeglumine, BAY86-4882)
Accepts Healthy Volunteer
N/A

Trial design

Open, uncontrolled study on the safety and efficacy of Gd-DTPA (SH L 451 AA) in magnetic resonance imaging (MRI) of CNS lesions in children (6 to 12 years)
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A